StrideBio Funding: $82M Raised, Series B (2021)

StrideBio is based in Durham. It has raised $82M in total funding. Latest round: Series B. Backed by Northpond Ventures, Novo Holdings A/S, Pontifax.

StrideBio funding overview

StrideBio is based in Durham. StrideBio has raised $82M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in March 2021. The round record for StrideBio runs through 2021; nothing later has been disclosed. Investors on record include Northpond Ventures, Novo Holdings A/S, Pontifax, Octagon Capital, Sarepta Therapeutics, CaaS Capital and 5 others. 11 distinct backers are named across the disclosed rounds.

StrideBio at a glance

Total raised
$82M
Latest round
Series B
Latest round date
March 2021
Headquarters
Durham
Notable investors
Northpond Ventures, Novo Holdings A/S, Pontifax, Octagon Capital, Sarepta Therapeutics, CaaS Capital, UF Innovate Ventures, Hatteras Venture Partners

Frequently asked about StrideBio funding

How much has StrideBio raised?
StrideBio has raised $82M in total disclosed funding across the rounds on record.
Who has invested in StrideBio?
Northpond Ventures, Novo Holdings A/S, Pontifax, Octagon Capital, Sarepta Therapeutics, CaaS Capital are named among the investors backing StrideBio.
What was the latest StrideBio funding round?
The most recent disclosed round is a Series B, announced in March 2021.
Where is StrideBio based?
StrideBio is based in Durham.
When did StrideBio last raise?
The last disclosed StrideBio round closed in March 2021 at Series B.

StrideBio totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Durham below to benchmark round size and investor mix.

Companies related to StrideBio (36)

Browse related funding lists (7)

Company funding database · Investor directory · Founder database · Mega-rounds 2026